# NEUP (Neuphoria Therapeutics Inc.) - SEC EDGAR Financial Statements

> Neuphoria Therapeutics Inc. reported $1.17M in revenue and a net loss of $4.97M for the fiscal year ended June 30, 2026 (down 92.5% year over year), with a -1098.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/NEUP
- Markdown: https://convexityos.com/fundamentals/NEUP.md
- SEC CIK: 0001191070
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:05 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001191070&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | $1.17M | -92.5% YoY |
| Operating Income | FY 2026 | -$12.89M | -1098.1% margin |
| Net Income | FY 2026 | -$4.97M | -423.3% net margin |
| Diluted EPS | FY 2026 | -$0.92 | Split-adjusted |
| Free Cash Flow | FY 2026 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $18.74M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- | --- |
| **Revenue** | $1.17M | $15.65M | -- | -- |
| Research & Development | -- | $9.01M | $9.42M | $13.07M |
| Total Operating Expenses | $17.63M | $16.78M | $17.89M | $21.98M |
| **Operating Income** | -$16.45M | -$1.13M | -$17.89M | -$21.98M |
| **EBITDA** | -$15.79M | -$466K | -$17.23M | -$21.32M |
| Interest Income | $666K | $166K | $220K | $323K |
| Income Before Tax | -$13.59M | -$838K | -$15.58M | -$21.52M |
| Income Tax Expense | -$139K | -$468K | -$87K | -$139K |
| **Net Income** | -$13.45M | -$370K | -$15.49M | -$21.38M |
| Basic EPS | -$3.06 | -$0.23 | -$18.62 | -$0.02 |
| **Diluted EPS** | -$3.06 | -$0.23 | -$18.62 | -$0.02 |
| Basic Shares Outstanding | 4.4M | 1.6M | 832.2K | 1.47B |
| Diluted Shares Outstanding | 4.4M | 1.6M | 832.2K | 1.47B |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | $15.00M | $663K |
| Research & Development | -- | -- | -- | $698K | $3.79M | $3.75M | $1.62M | $1.74M |
| Total Operating Expenses | $2.10M | $6.70M | $1.21M | $4.06M | $5.65M | $5.82M | $3.02M | $4.37M |
| **Operating Income** | -$2.10M | -$5.53M | -$1.21M | -$4.06M | -$5.65M | -$5.84M | $11.98M | -$3.70M |
| **EBITDA** | -$1.93M | -$5.36M | -$1.05M | -$3.90M | -$5.49M | -$5.67M | $12.14M | -$3.54M |
| Interest Income | $169K | $170K | $186K | $167K | $142K | $87K | $13K | $31K |
| Income Before Tax | -$1.46M | -$4.94M | -$540K | $1.83M | -$9.94M | -$9.15M | $11.18M | -$1.93M |
| Income Tax Expense | -$35K | -$35K | -$35K | -$35K | -$35K | -$267K | -$81K | $12K |
| **Net Income** | -$1.43M | -$4.90M | -$505K | $1.86M | -$9.91M | -$8.88M | $11.26M | -$1.94M |
| Basic EPS | -$0.26 | -- | -$0.09 | $0.41 | -$4.41 | -- | $6.55 | -$1.23 |
| **Diluted EPS** | -$0.26 | -- | -$0.09 | -$0.77 | -$4.41 | -- | $6.55 | -$1.79 |
| Basic Shares Outstanding | 5.4M | -- | 5.4M | 4.5M | 2.2M | -- | 1.7M | 1.6M |
| Diluted Shares Outstanding | 5.4M | -- | 5.4M | 4.5M | 2.2M | -- | 1.7M | 1.6M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $19.87M | $14.21M | $12.61M | $12.10M |
| **Cash & Short-Term Investments** | $19.87M | $14.21M | $12.61M | $12.10M |
| Accounts Receivable, Net | $813K | $12K | $127K | $426K |
| **Total Current Assets** | $21.07M | $15.04M | $13.19M | $13.33M |
| Property, Plant & Equipment, Net | -- | $2.8K | $2.0K | $2.5K |
| Goodwill | $3.50M | $8.64M | $8.69M | $8.69M |
| Intangible Assets | $4.14M | $4.80M | $5.47M | $6.13M |
| **Total Non-Current Assets** | $7.64M | $13.55M | $14.46M | $15.24M |
| **Total Assets** | $28.71M | $28.59M | $27.65M | $28.56M |
| Accounts Payable | $386K | $1.15M | $2.24M | $1.44M |
| **Total Current Liabilities** | $757K | $4.22M | $3.83M | $2.74M |
| Other Non-Current Liabilities | -- | -- | $2.9K | $15K |
| **Total Non-Current Liabilities** | $3.35M | $5.37M | $6.33M | $3.81M |
| **Total Liabilities** | $4.11M | $9.59M | $10.16M | $6.55M |
| **Total Debt (incl. Leases)** | -- | $116K | $240K | $354K |
| Common Stock | $54 | $19 | $11 | -- |
| Retained Earnings | -$191.8M | -$178.3M | -$178.0M | -$162.5M |
| Accumulated Other Comp. Income | -$2.06M | -$2.85M | -$3.01M | -$3.06M |
| **Total Stockholders' Equity** | $24.60M | $19.00M | $24.60M | $22.01M |
| Total Equity | $24.60M | $19.00M | $24.60M | $22.01M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $18.74M | $19.87M | $19.44M | $22.17M | $13.65M | $14.21M | $17.04M | $4.34M |
| **Cash & Short-Term Investments** | $18.74M | $19.87M | $19.44M | $22.17M | $13.65M | $14.21M | $17.04M | $4.34M |
| Accounts Receivable, Net | $700K | $813K | $1.61M | $1.11M | $1.8K | $12K | $25K | $36K |
| **Total Current Assets** | $19.60M | $21.07M | $21.66M | $23.39M | $13.95M | $15.04M | $17.09M | $4.40M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | $2.6K | $2.8K | $1.6K | $1.7K |
| Goodwill | $3.53M | $3.50M | $8.84M | $8.74M | $8.67M | $8.64M | $8.45M | $8.41M |
| Intangible Assets | $3.98M | $4.14M | $4.31M | $4.47M | $4.64M | $4.80M | $4.97M | $5.14M |
| **Total Non-Current Assets** | $7.50M | $7.64M | $13.15M | $13.21M | $13.39M | $13.55M | $13.62M | $13.77M |
| **Total Assets** | $27.11M | $28.71M | $34.81M | $36.60M | $27.34M | $28.59M | $30.71M | $18.17M |
| Accounts Payable | $725K | $386K | $627K | $521K | $1.37M | $1.15M | $745K | $1.53M |
| **Total Current Liabilities** | $1.09M | $757K | $1.51M | $2.59M | $5.12M | $4.22M | $1.55M | $2.13M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | $3.6K | $3.4K |
| **Total Non-Current Liabilities** | $2.55M | $3.35M | $3.87M | $4.31M | $9.71M | $5.37M | $3.16M | $2.29M |
| **Total Liabilities** | $3.63M | $4.11M | $5.39M | $6.90M | $14.83M | $9.59M | $4.72M | $4.42M |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | $85K | $116K | $141K | $168K |
| Common Stock | $54 | $54 | $54 | $54 | $23 | $19 | $19 | $16 |
| Retained Earnings | -$193.2M | -$191.8M | -$186.9M | -$186.4M | -$188.3M | -$178.3M | -$169.5M | -$180.7M |
| Accumulated Other Comp. Income | -$1.84M | -$2.06M | -$2.07M | -$2.23M | -$2.80M | -$2.85M | -$3.91M | -$3.74M |
| **Total Stockholders' Equity** | $23.47M | $24.60M | $29.42M | $29.70M | $12.51M | $19.00M | $26.00M | $13.75M |
| Total Equity | $23.47M | $24.60M | $29.42M | $29.70M | $12.51M | $19.00M | $26.00M | $13.75M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- | --- |
| Net Income | -$13.45M | -$370K | -$15.49M | -$21.38M |
| Depreciation & Amortization | $663K | $663K | $663K | $663K |
| Stock-Based Compensation | $352K | $164K | $815K | $1.35M |
| Change in Receivables | -$801K | $115K | $299K | $4.14M |
| Change in Payables | -$769K | -$918K | $804K | $374K |
| **Operating Cash Flow** | -$12.35M | $77K | -$14.68M | -$14.64M |
| Common Stock Issued | $17.92M | $1.53M | $10.11M | -- |
| **Financing Cash Flow** | $17.92M | $1.53M | $15.11M | $3.86M |
| **Net Change in Cash** | $5.58M | $1.60M | $505K | -$10.78M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.43M | -$4.90M | -$505K | $1.86M | -$9.91M | -$8.88M | $11.26M | -$1.94M |
| Depreciation & Amortization | $166K | $166K | $166K | $166K | $166K | $166K | $165K | $166K |
| Stock-Based Compensation | $75K | $76K | $70K | $94K | $111K | $98K | $20K | $19K |
| Change in Receivables | $113K | $792K | -$495K | -$1.11M | $10K | $13K | $11K | $80K |
| Change in Payables | $339K | -$242K | $106K | -$850K | $216K | $581K | -$785K | $205K |
| **Operating Cash Flow** | -$1.13M | $1.21M | -$3.34M | -$6.44M | -$3.79M | -$3.59M | $11.45M | -$3.36M |
| Common Stock Issued | -- | $0 | $0 | $14.66M | $3.25M | $705K | $824K | $0 |
| **Financing Cash Flow** | -- | $0 | $0 | $14.66M | $3.25M | $705K | $1.16M | -$112K |
| **Net Change in Cash** | -$1.12M | $425K | -$2.81M | $8.52M | -$560K | -$2.83M | $12.70M | -$3.75M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- | --- |
| **Operating Margin** | -1401.1% | -7.2% | -- | -- |
| **Net Profit Margin** | -1145.7% | -2.4% | -- | -- |
| Return on Equity (ROE) | -54.7% | -1.9% | -63.0% | -97.1% |
| Return on Assets (ROA) | -46.9% | -1.3% | -56.0% | -74.9% |
| Current Ratio | 27.85x | 3.56x | 3.45x | 4.87x |
| Quick Ratio | 27.33x | 3.37x | 3.33x | 4.57x |
| Debt to Equity | -- | 0.01x | 0.01x | 0.02x |
| **Revenue Growth (YoY)** | -92.5% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -16095.4% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -21.2% | -54.7% | -59.2% | -19.1% | -75.7% | -1.9% | 22.4% | -59.7% |
| Return on Assets (ROA) | -18.3% | -46.9% | -50.1% | -15.5% | -34.6% | -1.3% | 19.0% | -45.2% |
| Current Ratio | 18.05x | 27.85x | 14.31x | 9.04x | 2.72x | 3.56x | 11.01x | 2.06x |
| Quick Ratio | 17.91x | 27.33x | 13.91x | 9.00x | 2.66x | 3.37x | 11.00x | 2.05x |
| Debt to Equity | -- | -- | -- | -- | 0.01x | 0.01x | 0.01x | 0.01x |
| Operating Income Growth (YoY) | -- | -- | -110.1% | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -104.5% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -101.4% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -129.1% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
